Ruiping Du

Science Island Branch
Hefei, 230026, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Protocol to isolate broadly neutralizing monoclonal antibodies against SARS-CoV-2 from human B cells.

Protocol to isolate broadly neutralizing monoclonal antibodies against SARS-CoV-2 from human B cells.

Journal: STAR protocols
Published: September 08, 2025

Discovery of Synergistic Broadly Neutralizing Antibodies Targeting Non-Dominant Epitopes on SARS-CoV-2 RBD and NTD.

Discovery of Synergistic Broadly Neutralizing Antibodies Targeting Non-Dominant Epitopes on SARS-CoV-2 RBD and NTD.

Journal: Vaccines
Published: April 27, 2025

Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.

Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.

Journal: Scientific reports
Published: March 03, 2025

A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls.

A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls.

Journal: Cell reports
Published: December 20, 2024

Disulfiram potentiates cisplatin-induced apoptosis in small cell lung cancer via the inhibition of cystathionine β-synthase and H2S.

Disulfiram potentiates cisplatin-induced apoptosis in small cell lung cancer via the inhibition of cystathionine β-synthase and H2S.

Journal: American journal of cancer research
Published: November 25, 2024

Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections.

Ancestral SARS-CoV-2 immune imprinting persists on RBD but not NTD after sequential Omicron infections.

Journal: iScience
Published: October 08, 2024

Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer.

Cisplatin resistance-related transcriptome and methylome integration identifies PCDHB4 as a novel prognostic biomarker in small cell lung cancer.

Journal: iScience
Published: November 10, 2023

Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer.

Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer.

Journal: Anti-cancer agents in medicinal chemistry
Published: December 11, 2022
Showing 1-8 of 8

Last Updated: 09/26/2026